Agility robotics/X
Company Agility Robotics recently announced that preparations are in all swing for the opening of this manufacturing unit named “RoboFab.” The Agility’s press release mentioned that the facility’s construction began last year.
A major upgrade of the Linac Coherent Light Source has been completed at the SLAC National Accelerator Laboratory, California. This latest version is 8,000 times faster and 10,000 times brighter, enabling scientists to observe molecular events in unprecedented detail.
Credit: Greg Stewart.
The newly upgraded Linac Coherent Light Source (LCLS) X-ray free-electron laser (XFEL) at California’s SLAC National Accelerator Laboratory has successfully produced its first X-rays, and researchers around the world are lined up to kick off an ambitious science program. The upgrade, called LCLS-II, now makes it the world’s most powerful X-ray laser, surpassing the European XFEL near Hamburg, Germany.
She explains why, and gives the stock a 2027 price target representing massive upside.
As befits the child of a scientist, Martin Picard’s young son, 3, is already learning about biology with an age-appropriate textbook, “Cell Biology for Babies.” Picard winces a little whenever the book calls mitochondria the “powerhouses of the cell” but figures he has plenty of time as his son grows older to explain why the tiny organelles are much more than simple energy sources.
Picard is a leading proponent of mitochondrial psychobiology (a phrase he coined), an emerging field that examines how psychological states like stress influence mitochondrial functions, which in turn influence mental and physical health.
“The powerhouse analogy is outdated and one-dimensional and can impede science by limiting researchers’ perceptions of what mitochondria can do,” says Picard, associate professor of behavioral medicine in psychiatry and neurology.
The chipmaker is developing a sequel to its Tunnel Falls quantum processor. Quantum computing in coming years could improve batteries, finance and AI.
Google DeepMind has used its technology to identify parts of human DNA that might cause diseases.
Here are some more specs: Frontier uses approximately 50,000 processors, compared with the most powerful laptop’s 16 or 24. It consumes 20 million watts, compared with a laptop’s 65 or so. It cost $600 million to build.
When Frontier came online, it marked the dawn of so-called exascale computing, with machines that can execute an exaflop—or a quintillion (1018) floating point operations a second. Since then, scientists have geared up to make more of these blazingly fast computers: several exascale machines are due to come online in the US and Europe in 2024.
From Iran to China to Russia, there’s an escalating ‘cat-and-mouse’ game between the censors and those trying to evade them.
I want to talk about the battle that’s raging every day between people who want to censor online content and those who want to protect access to a free and open internet.
It also relates to a recent scoop about a new Google product that’s designed to make it easier for developers to build censorship-resistant apps. I’ve said it before and I’ll say it again: this is a space worth paying attention to.
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
As the smallest living units, cells are key to understanding disease—and yet so much about them remains unknown. We do not know, for example, how billions of biomolecules—like DNA, proteins, and lipids—come together to act as one cell. Nor do we know how our many types of cells interact within our bodies. We have limited understanding of how cells, tissues, and organs become diseased and what it takes for them to be healthy.
AI can help us answer these questions and apply that knowledge to improve health and well-being worldwide—if… More.
CHOP researchers established the feasibility of an artificial womb called the “Biobag” to nurture a premature lamb in 2017.
The US Food and Drug Administration (FDA) will hold a meeting of independent advisors on September 19–20. The meeting’s agenda is to discuss the viability of clinical trials using artificial womb technology to improve the survival and health of extremely preterm newborns.
Reportedly, during this meeting, regulators and experts will delve into ethical concerns and evaluate various crucial aspects, including the potential steps and design of human trials for this technology.